EP4306529
FGFR INHIBITORS AND METHODS OF USE THEREOF
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
12.5.2020EP published:
21.1.2026EP application number:
23210430.7
EPO information:
European Patent Register
Max expiry date:
11.5.2040Expiry date:
20.5.2026
Title in English:
FGFR INHIBITORS AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
12.5.2020EP application
21.1.2026EP Publication
20.5.2026Expires
Owner
Name:
Relay Therapeutics, Inc.Address:
399 Binney Street Second Floor, Cambridge, MA 02139, US
Inventor
Name:
TOURÉ, Bakary-BarryAddress:
Cambridge, 02139, US
Name:
SCHOENHERR, HeikeAddress:
Cambridge, 02139, US
Name:
TAYLOR, Alexander M.Address:
Cambridge, 02139, US
Name:
GIORDANETTO, FabrizioAddress:
New York, 10036, US
Name:
MOUSTAKAS, Demetri T.Address:
Cambridge, 02139, US
Name:
MCLEAN, Thomas H.Address:
Cambridge, 02139, US
Name:
HUDSON, Brandi M.Address:
Cambridge, 02139, US
Name:
MADER, Mary M.Address:
Cambridge, 02139, US
Name:
AYAZ, PelinAddress:
New York, 10036, US
Name:
SHARON, Dina A.Address:
New York, 10036, US
Name:
KURUKULASURIYA, RaviAddress:
Cambridge, 02139, US
Name:
BOEZIO, AlessandroAddress:
Cambridge, 02139, US
Priority
Number:
201962846991 PDate:
13.5.2019Country:
US
Number:
202062993957 PDate:
24.3.2020Country:
US
Number:
202063011469 PDate:
17.4.2020Country:
US
Classification
Categories:
C07D 519/00, C07D 471/14, C07D 487/04, C07D 491/04, C07D 498/04, C07D 498/22, A61P 35/00, C07D 471/04